Page last updated: 2024-08-24

pobilukast and Lung Diseases, Obstructive

pobilukast has been researched along with Lung Diseases, Obstructive in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haswell, M; Hill, A; Jackson, N; Jackson, S; Kilfeather, S; Lee, E; Lindo, T; Meng-Choong, L; Reynolds, P1

Other Studies

1 other study(ies) available for pobilukast and Lung Diseases, Obstructive

ArticleYear
Reversal of human neutrophil survival by leukotriene B(4) receptor blockade and 5-lipoxygenase and 5-lipoxygenase activating protein inhibitors.
    American journal of respiratory and critical care medicine, 1999, Volume: 160, Issue:6

    Topics: 5-Lipoxygenase-Activating Proteins; Acrylates; Adult; Apoptosis; Arachidonate 5-Lipoxygenase; Benzeneacetamides; Carrier Proteins; Cell Survival; Dexamethasone; Dicarboxylic Acids; Dose-Response Relationship, Drug; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hydroxamic Acids; In Vitro Techniques; Indoles; Leukotriene Antagonists; Leukotriene B4; Lipopolysaccharides; Lipoxygenase Inhibitors; Lung Diseases, Obstructive; Membrane Proteins; Neutrophils; Pyridines; Receptors, Leukotriene B4

1999